Allspring Global Investments Holdings LLC Has 1.54 Million Stock Holdings in Innoviva, Inc. - MarketBeat
INVA Stock | USD 18.85 0.15 0.79% |
About 56% of all Innoviva's investors are looking to take a long position. The analysis of overall sentiment of trading Innoviva stock suggests that some investors are interested at this time. The current market sentiment, together with Innoviva's historical and current headlines, can help investors time the market. In addition, many technical investors use Innoviva stock news signals to limit their universe of possible portfolio assets.
Innoviva |
Allspring Global Investments Holdings LLC Has 1.54 Million Stock Holdings in Innoviva, Inc. MarketBeat
Read at news.google.com
Innoviva Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Innoviva can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Innoviva Fundamental Analysis
We analyze Innoviva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innoviva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innoviva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Innoviva is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Innoviva Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innoviva stock to make a market-neutral strategy. Peer analysis of Innoviva could also be used in its relative valuation, which is a method of valuing Innoviva by comparing valuation metrics with similar companies.
Peers
Innoviva Related Equities
XFOR | X4 Pharmaceuticals | 13.43 | ||||
ABOS | Acumen Pharmaceuticals | 0.46 | ||||
FOLD | Amicus Therapeutics | 0.20 | ||||
INCY | Incyte | 0.06 | ||||
DAWN | Day One | 0.45 | ||||
ARGX | Argenx NV | 0.59 | ||||
INZY | Inozyme Pharma | 0.67 | ||||
HRMY | Harmony Biosciences | 1.28 | ||||
PLX | Protalix Biotherapeutics | 1.64 | ||||
APLS | Apellis Pharmaceuticals | 1.85 | ||||
DNLI | Denali Therapeutics | 2.53 | ||||
PDSB | PDS Biotechnology | 2.80 | ||||
AMLX | Amylyx Pharmaceuticals | 3.10 | ||||
TERN | Terns Pharmaceuticals | 3.18 | ||||
ELEV | Elevation Oncology | 4.00 | ||||
HOOK | Hookipa Pharma | 7.88 |
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |